Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndrome

This publication has 55 references indexed in Scilit:

• Cilansetron shows efficacy in male and female non-constipated patients with irritable bowel syndrome in a United States study
  Gastroenterology, 2001
• Allelic Variation in the Serotonin Transporter Promoter Affects Onset of Paroxetine Treatment Response in Late-Life Depression
  Neuropsychopharmacology, 2000
• Alosetron does not improve anxiety in female IBS patients
  Gastroenterology, 2000
• Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5‐HT₃ receptor antagonist
  Alimentary Pharmacology & Therapeutics, 1999
• Potential associations among genetic markers in the serotonergic system and the antisocial alcoholism subtype.
  Experimental and Clinical Psychopharmacology, 1999
• Allelic Variation of Human Serotonin Transporter Gene Expression
  Journal of Neurochemistry, 1996
• Altered rectal perception is a biological marker of patients with irritable bowel syndrome
  Gastroenterology, 1995
• Serotonergic mediation of postprandial colonic tonic and phasic responses in humans.
  Gut, 1994
• Reduction of rectal sensitivity and post‐prandial motility by granisetron, a 5 HT₃‐receptor antagonist, in patients with irritable bowel syndrome
  Alimentary Pharmacology & Therapeutics, 1993
• Towards a less costly but accurate test of gastric emptying and small bowel transit
  Digestive Diseases and Sciences, 1991